Global Pharmaceutical Intermediates Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 127

Report ID: 9083

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need will increase.
The industry is a high-technology and high-profit industry, the research team maintain a very optimistic attitude. It is suggested that the new enterprises to enter the field.
We tend to believe this industry now is close to mature, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
The global Pharmaceutical Intermediates market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pharmaceutical Intermediates market based on company, product type, end user and key regions.

This report studies the global market size of Pharmaceutical Intermediates in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pharmaceutical Intermediates in these regions.
This research report categorizes the global Pharmaceutical Intermediates market by top players/brands, region, type and end user. This report also studies the global Pharmaceutical Intermediates market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lonza
Catalent
Patheon
Jubilant 
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai

Market size by Product
GMP
Non-GMP
Market size by End User
Antibiotics
Antipyretic Analgesics
Vitamins
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pharmaceutical Intermediates market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pharmaceutical Intermediates market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pharmaceutical Intermediates companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pharmaceutical Intermediates submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pharmaceutical Intermediates are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pharmaceutical Intermediates market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Pharmaceutical Intermediates Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Product
1.4.2 GMP
1.4.3 Non-GMP
1.5 Market by End User
1.5.1 Global Pharmaceutical Intermediates Market Size Growth Rate by End User
1.5.2 Antibiotics
1.5.3 Antipyretic Analgesics
1.5.4 Vitamins
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pharmaceutical Intermediates Market Size
2.1.1 Global Pharmaceutical Intermediates Revenue 2014-2025
2.1.2 Global Pharmaceutical Intermediates Sales 2014-2025
2.2 Pharmaceutical Intermediates Growth Rate by Regions
2.2.1 Global Pharmaceutical Intermediates Sales by Regions
2.2.2 Global Pharmaceutical Intermediates Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Pharmaceutical Intermediates Sales by Manufacturers
3.1.2 Pharmaceutical Intermediates Sales Market Share by Manufacturers
3.1.3 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.2 Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Pharmaceutical Intermediates Revenue by Manufacturers (2014-2019)
3.2.2 Pharmaceutical Intermediates Revenue Share by Manufacturers (2014-2019)
3.3 Pharmaceutical Intermediates Price by Manufacturers
3.4 Pharmaceutical Intermediates Manufacturing Base Distribution, Product Types
3.4.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharmaceutical Intermediates Product Type
3.4.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Pharmaceutical Intermediates Sales by Product
4.2 Global Pharmaceutical Intermediates Revenue by Product
4.3 Pharmaceutical Intermediates Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Pharmaceutical Intermediates Breakdown Data by End User

6 North America
6.1 North America Pharmaceutical Intermediates by Countries
6.1.1 North America Pharmaceutical Intermediates Sales by Countries
6.1.2 North America Pharmaceutical Intermediates Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pharmaceutical Intermediates by Product
6.3 North America Pharmaceutical Intermediates by End User

7 Europe
7.1 Europe Pharmaceutical Intermediates by Countries
7.1.1 Europe Pharmaceutical Intermediates Sales by Countries
7.1.2 Europe Pharmaceutical Intermediates Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pharmaceutical Intermediates by Product
7.3 Europe Pharmaceutical Intermediates by End User

8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Intermediates by Countries
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Countries
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pharmaceutical Intermediates by Product
8.3 Asia Pacific Pharmaceutical Intermediates by End User

9 Central & South America
9.1 Central & South America Pharmaceutical Intermediates by Countries
9.1.1 Central & South America Pharmaceutical Intermediates Sales by Countries
9.1.2 Central & South America Pharmaceutical Intermediates Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pharmaceutical Intermediates by Product
9.3 Central & South America Pharmaceutical Intermediates by End User

10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical Intermediates by Countries
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Countries
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pharmaceutical Intermediates by Product
10.3 Middle East and Africa Pharmaceutical Intermediates by End User

11 Company Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Company Business Overview
11.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Company Business Overview
11.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Catalent Pharmaceutical Intermediates Products Offered
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Company Business Overview
11.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Patheon Pharmaceutical Intermediates Products Offered
11.3.5 Patheon Recent Development
11.4 Jubilant 
11.4.1 Jubilant  Company Details
11.4.2 Company Business Overview
11.4.3 Jubilant  Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Jubilant  Pharmaceutical Intermediates Products Offered
11.4.5 Jubilant  Recent Development
11.5 Granules
11.5.1 Granules Company Details
11.5.2 Company Business Overview
11.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Granules Pharmaceutical Intermediates Products Offered
11.5.5 Granules Recent Development
11.6 Ganesh
11.6.1 Ganesh Company Details
11.6.2 Company Business Overview
11.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Ganesh Pharmaceutical Intermediates Products Offered
11.6.5 Ganesh Recent Development
11.7 Chemcon
11.7.1 Chemcon Company Details
11.7.2 Company Business Overview
11.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Chemcon Pharmaceutical Intermediates Products Offered
11.7.5 Chemcon Recent Development
11.8 BASF
11.8.1 BASF Company Details
11.8.2 Company Business Overview
11.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.8.4 BASF Pharmaceutical Intermediates Products Offered
11.8.5 BASF Recent Development
11.9 Porton
11.9.1 Porton Company Details
11.9.2 Company Business Overview
11.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Porton Pharmaceutical Intermediates Products Offered
11.9.5 Porton Recent Development
11.10 Lianhetech
11.10.1 Lianhetech Company Details
11.10.2 Company Business Overview
11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
11.10.5 Lianhetech Recent Development
11.11 ABA Chem
11.12 Tianma
11.13 Jiujiujiu
11.14 Alpha
11.15 Jiuzhou
11.16 Yongtai

12 Future Forecast
12.1 Pharmaceutical Intermediates Market Forecast by Regions
12.1.1 Global Pharmaceutical Intermediates Sales Forecast by Regions 2019-2025
12.1.2 Global Pharmaceutical Intermediates Revenue Forecast by Regions 2019-2025
12.2 Pharmaceutical Intermediates Market Forecast by Product
12.2.1 Global Pharmaceutical Intermediates Sales Forecast by Product 2019-2025
12.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Product 2019-2025
12.3 Pharmaceutical Intermediates Market Forecast by End User
12.4 North America Pharmaceutical Intermediates Forecast
12.5 Europe Pharmaceutical Intermediates Forecast
12.6 Asia Pacific Pharmaceutical Intermediates Forecast
12.7 Central & South America Pharmaceutical Intermediates Forecast
12.8 Middle East and Africa Pharmaceutical Intermediates Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pharmaceutical Intermediates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer